$125 | Single User
$250 | Site License
$375 | Global License

bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 02 May 2019 | 231458 | In Stock

Introduction

bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaboration with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

bluebird bio Inc Key Recent Developments

May 01,2019 bluebird bio appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer

Apr 16,2019 bluebird bio: Entry into a Material Definitive Agreement

Mar 25,2019 bluebird bio Statement on European Regulatory Status of LentiGlobin

Mar 22,2019 Bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents

    List of Tables

    List of Figures

    Section 1 - About the Company

    bluebird bio Inc - Key Facts

    bluebird bio Inc - Key Employees

    bluebird bio Inc - Key Employee Biographies

    bluebird bio Inc - Major Products and Services

    bluebird bio Inc - History

    bluebird bio Inc - Company Statement

    bluebird bio Inc - Locations And Subsidiaries

    Head Office

    Other Locations & Subsidiaries

    Section 2 – Company Analysis

    Company Overview

    bluebird bio Inc - Business Description

    bluebird bio Inc - Corporate Strategy

    bluebird bio Inc - SWOT Analysis

    SWOT Analysis - Overview

    bluebird bio Inc - Strengths

    bluebird bio Inc - Weaknesses

    bluebird bio Inc - Opportunities

    bluebird bio Inc - Threats

    bluebird bio Inc - Key Competitors

    Section 3 – Company Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Performance Chart

    Financial Performance

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 – Company’s Lifesciences Financial Deals and Alliances

    bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

    bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

    bluebird bio Inc, Recent Deals Summary

    Section 5 – Company’s Recent Developments

    May 01, 2019: bluebird bio appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer

    Apr 16, 2019: bluebird bio: Entry into a Material Definitive Agreement

    Mar 25, 2019: bluebird bio Statement on European Regulatory Status of LentiGlobin

    Mar 22, 2019: Bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

    Mar 22, 2019: bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

    Feb 21, 2019: bluebird bio reports fourth quarter and full year 2018 financial results and highlights operational progress

    Feb 21, 2019: bluebird bio reports fourth quarter and full year 2018 financial results and highlights operational progress

    Feb 11, 2019: bluebird bio names Chip Baird as Chief Financial Officer

    Nov 21, 2018: Cryoport Opens Logistics Center in Livingston, NJ, US

    Nov 01, 2018: bluebird bio reports third quarter 2018 financial results and highlights operational progress

    Section 6 – Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

List Of Tables
in bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

bluebird bio Inc, Key Facts

bluebird bio Inc, Key Employees

bluebird bio Inc, Key Employee Biographies

bluebird bio Inc, Major Products and Services

bluebird bio Inc, History

bluebird bio Inc, Other Locations

bluebird bio Inc, Subsidiaries

bluebird bio Inc, Key Competitors

bluebird bio Inc, Ratios based on current share price

bluebird bio Inc, Annual Ratios

bluebird bio Inc, Annual Ratios (Cont...1)

bluebird bio Inc, Interim Ratios

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

bluebird bio Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

bluebird bio Inc, Performance Chart (2014 - 2018)

bluebird bio Inc, Ratio Charts

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Additional Details

Publisher

Global Data

Publisher Information

Reference

231458 |

Number of Pages

53

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
bluebird bio Inc (BLUE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryBluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company, which researches a...
16 Mar 2017 by Global Data USD $250 More Info
bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review
bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth stra...
15 Mar 2017 by Global Data USD $125 More Info
bluebird bio Inc (BLUE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summarybluebird bio Inc (bluebird bio) is a clinical stage biotechnology company, which researches a...
22 Nov 2016 by Global Data USD $250 More Info
bluebird bio, Inc. (BLUE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summarybluebird bio, Inc. (bluebird bio) is a clinical stage biotechnology company, which researches...
24 Aug 2016 by Global Data USD $250 More Info
bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review
bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
10 May 2016 by Global Data USD $300 More Info
Bluebird bio, Inc. (BLUE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summarybluebird bio, Inc. (bluebird bio) is a clinical stage biotechnology company, which researches...
05 May 2016 by Global Data USD $250 More Info
Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review
Summarybluebird bio, Inc. (bluebird bio) is a biotechnology company that research and develops new g...
15 Apr 2016 by Global Data USD $300 More Info
Bluebird bio, Inc. (BLUE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summarybluebird bio, Inc. (bluebird bio) is a biotechnology company that research and develops new g...
09 Mar 2016 by Global Data USD $250 More Info
Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review
Summarybluebird bio, Inc. (bluebird bio) is a biotechnology company that research and develops new g...
09 Jan 2016 by Global Data USD $300 More Info
Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review
Summarybluebird bio, Inc. (bluebird bio) is a biotechnology company that research and develops new g...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...